Literature DB >> 11119624

Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

T Tolfvenstam1, A Oxenius, D A Price, B L Shacklett, H M Spiegel, K Hedman, O Norbeck, M Levi, K Olsen, M Kantzanou, D F Nixon, K Broliden, P Klenerman.   

Abstract

Parvovirus B19 is a common human pathogen which can cause severe syndromes, including aplastic anemia and fetal hydrops. The mapping of the first parvovirus B19-derived CD8(+) T-lymphocyte epitope is described. This HLA-B35-restricted peptide derives from the nonstructural (NS1) protein and is strongly immunogenic in B19 virus-seropositive donors.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11119624      PMCID： PMC113948          DOI： 10.1128/JVI.75.1.540-543.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Role of human parvovirus B19 in the pathogenesis of rheumatoid arthritis.

Authors:  K K Ishii; Y Takahashi; M Kaku; T Sasaki
Journal:  Jpn J Infect Dis       Date:  1999-10       Impact factor: 1.362

2.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

3.  Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis.

Authors:  H D Stahl; B Hubner; B Seidl; U G Liebert; I M van der Heijden; B Wilbrink; M C Kraan; F Emmrich; P P Tak
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 5.  Human parvoviruses.

Authors:  L J Anderson
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

6.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Chronic parvovirus infection in a presumably immunologically healthy woman.

Authors:  H Faden; G W Gary; L J Anderson
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

8.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

Authors:  R M Zinkernagel; E Haenseler; T Leist; A Cerny; H Hengartner; A Althage
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307
View more
  6 in total

1.  Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine.

Authors:  Candida Fasano; Darja Kanduc
Journal:  Self Nonself       Date:  2011-04-01

2.  Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans.

Authors:  Oscar Norbeck; Adiba Isa; Christoph Pöhlmann; Kristina Broliden; Victoria Kasprowicz; Paul Bowness; Paul Klenerman; Thomas Tolfvenstam
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.

Authors:  T C Harder; M Hufnagel; K Zahn; K Beutel; H J Schmitt; U Ullmann; P Rautenberg
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 4.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.

Authors:  Ruth Simmons; Colin Sharp; Stuart Sims; Henrik Kloverpris; Philip Goulder; Peter Simmonds; Paul Bowness; Paul Klenerman
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

6.  Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

Authors:  Adiba Isa; Victoria Kasprowicz; Oscar Norbeck; Andrew Loughry; Katie Jeffery; Kristina Broliden; Paul Klenerman; Thomas Tolfvenstam; Paul Bowness
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.